Last reviewed · How we verify

NCT05905081

Acute Effects of Moderate Intensity Aerobic Exercise on Cognitive Functions in Young Adult Males

Completed NA Last updated 13 September 2023
What this trial tests

NA trial testing aerobic exercise in Cognitive Change in 61 participants. Completed in 1 September 2023.

Timeline
20 June 2023
Primary endpoint
1 September 2023
1 September 2023

Quick facts

Lead sponsorIzmir University of Economics
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposebasic science
Enrollment61
Start date20 June 2023
Primary completion1 September 2023
Estimated completion1 September 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Izmir University of Economics

Who can join

Adults 18 to 25, male only, with Cognitive Change. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

60 healthy male university students will be included in this study. Physical fitness parameters, fluid intelligence, and physical activity level will be measured at baseline. Participants will be randomised to one of two testing schedules, groups will complete either a 30-minutes aerobic exercise session or a resting control condition. Cognitive measures (simple reaction time task, go/nogo task, spatial cueing, n-back task) will be tested before and after the intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of aerobic exercise

Trials testing the same drug.

Other recruiting trials for Cognitive Change

Currently open trials in the same condition.

Other Izmir University of Economics trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05905081.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing